CMV si scdaoitesa tihw nniftcgei arnog ttplnaansr .pntseita VCM is msantdrttie vai exasul a,cctont grnoa natrlpa,nst or yavliertlc iav etncap.la oRtniceavita of CVM rsucco in eth pieespumo.sudnrsm
ngOra nsnprtalta tpetinsa are ta an idercensa rkis of VCM m.iaupnnoe
he aws ernve einvg aivoricngcl - i desu htat sa a leuc voer rtaanlspnt jineecrot
Wyh wdoul iths ont eb tueac anlptnarts rieeojnct genaldi ot ?ADRS heT eaieintrnc si dvea,eetl nda I ese yna oerans wyh it uldow be tleaeved ydbnoe oirjecnte
via @sammyj98 via UpToDate:
Universal prophylaxis with valganciclovir or ganciclovir is typically given to patients at risk for cytomegalovirus (CMV) reactivation (eg, seropositive recipients and those with seropositive donors). The duration of therapy often depends on the type of organ transplanted, the risk status of the patient, and individual institutional practice. Some transplant centers prefer to use a pre-emptive approach (eg, routine CMV viral load monitoring within initiation of treatment when reactivation becomes evident) for specific patient populations.
submitted by โamorah(115)
It can be re-accessed by making a purchase.
Purchase your membership here
$279$49Ferve t-&g; uler uot tfel ialcvruetnr fieural - XMTPMS sylipoaphrx -g;&t elur out usscPnmytieo needvKjciyoiri rslttannpa but on W/RBBCC in nuire -;g&t elur otu psaantrntl rtecjonei
vgnLeai CVM adn liapytac bytoecmuacmri as hte nainrmgei otw onps.toi VMC is omer klelyi in a rptlnnsata aett.pni
$279$49